Showing results (341-350 of 606) with videos related to
Sort By:
Pageof 61
Journal of the National Cancer Institute|February 8, 2012
Second malignant neoplasms and cardiovascular disease following radiotherapyLois B Travis, Andrea K Ng, James M Allan, et al.Pediatric Blood & Cancer|May 31, 2020
Whole-joint magnetic resonance imaging to assess osteonecrosis in pediatric patients with acute lymphoblastic lymphomaHiroto Inaba, Olga Varechtchouk, Michael D Neel, et al.Cancer Management and Research|October 6, 2017
A p53-regulated apoptotic gene signature predicts treatment response and outcome in pediatric acute lymphoblastic leukemiaRussell O Bainer, Matthew R Trendowski, Cheng Cheng, et al.Health Physics|January 1, 2014
Second malignant neoplasms and cardiovascular disease following radiotherapyLois B Travis, Andrea K Ng, James M Allan, et al.Blood|August 1, 2002
De novo purine synthesis inhibition and antileukemic effects of mercaptopurine alone or in combination with methotrexate in vivoThierry Dervieux, Timothy L Brenner, Yuen Y Hon, et al.Pediatric Blood & Cancer|July 25, 2006
Implementation of a data management program in a pediatric cancer unit in a low income countryLisa Ayoub, Ligia Fú, Armando Peña, et al.Pediatric Blood & Cancer|July 31, 2018
Influence of fitness on health status among survivors of acute lymphoblastic leukemiaCarmen L Wilson, Carrie R Howell, Robyn E Partin, et al.Human Reproduction (Oxford, England)|April 27, 2017
Effect of cranial irradiation on sperm concentration of adult survivors of childhood acute lymphoblastic leukemia: a report from the St. Jude Lifetime Cohort Study†Daniel M Green, Liang Zhu, Mingjuan Wang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 7, 2012
Proximal tubular secretion of creatinine by organic cation transporter OCT2 in cancer patientsGiuliano Ciarimboli, Cynthia S Lancaster, Eberhard Schlatter, et al.Pharmacogenetics|November 20, 2002
Genetic polymorphisms in CYP3A5, CYP3A4 and NQO1 in children who developed therapy-related myeloid malignanciesJavier G Blanco, Mathew J Edick, Michael L Hancock, et al.Pageof 61